All cases were associated with severe dehydration from vomiting or diarrhea
Sources Dellapiana, Gabriela, et al
Novo Nordisk and Hims & Hers Partner to Expand Semaglutide Access Stephen Appezzato Key Takeaways Agreement enables Hims & Hers users to access branded Ozempic 0.52 mg and Wegovy injectable 0.252.4 mg plus oral strengths 1.525 mg
These are among the largest weight-loss figures reported for any pharmacological agent in a Phase 2 obesity trial
En la DM2 tambin se encuentra alterado el efecto incretina como un evento secundario a otros defectos metablicos y no como un evento primario de la fisiopatologa de esta enfermedad 42 , demostrndose una resistencia a la accin de estas hormonas, en especial a la ltima fase de respuesta del GLP-1 43-45
Pairing GLP-1 therapy with SGLT-2 inhibitors, a drug class that reduces cardiovascular and renal risk through different mechanisms, may offer additive or synergistic protection across multiple aging pathways